Brewin Dolphin Wealth Management LTD Charles River Laboratories International, Inc. Transaction History
Brewin Dolphin Wealth Management LTD
- $917 Million
- Q2 2022
A detailed history of Brewin Dolphin Wealth Management LTD transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Brewin Dolphin Wealth Management LTD holds 65 shares of CRL stock, worth $11,452. This represents 0.0% of its overall portfolio holdings.
Number of Shares
65
Previous 65
-0.0%
Holding current value
$11,452
Previous $18,000
22.22%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CRL
# of Institutions
623Shares Held
55MCall Options Held
722KPut Options Held
847K-
Vanguard Group Inc Valley Forge, PA6.11MShares$1.08 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$896 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.29MShares$755 Million0.13% of portfolio
-
Ubs Group Ag2.39MShares$421 Million0.07% of portfolio
-
Allspring Global Investments Holdings, LLC2.29MShares$404 Million0.63% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $8.96B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...